SciSparc Ltd. (SPRC)
NASDAQ: SPRC · Real-Time Price · USD
4.330
-0.230 (-5.04%)
At close: Oct 7, 2025, 4:00 PM EDT
4.350
+0.020 (0.46%)
After-hours: Oct 7, 2025, 4:02 PM EDT
SciSparc Employees
SciSparc had 2 employees as of December 31, 2024. The number of employees decreased by 1 or -33.33% compared to the previous year.
Employees
2
Change (1Y)
-1
Growth (1Y)
-33.33%
Revenue / Employee
$653,000
Profits / Employee
-$3,142,000
Market Cap
2.38M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2 | -1 | -33.33% |
| Dec 31, 2023 | 3 | 0 | - |
| Dec 31, 2022 | 3 | 0 | - |
| Dec 31, 2021 | 3 | 1 | 50.00% |
| Dec 31, 2020 | 2 | -6 | -75.00% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
SPRC News
- 1 day ago - SciSparc Ltd. Announces Framework Agreement Regarding Merger with AutoMax Motors - GlobeNewsWire
- 8 days ago - SciSparc: N2OFF Shareholders Approve Merger with SciSparc's Majority Owned Subsidiary MitoCareX, a Drug Discovery Company Targeting Resistant Cancers Including Pancreatic and Non-Small Cell Lung Cancer - GlobeNewsWire
- 12 days ago - SciSparc Stock Surges As It Launches Initiative To Advance Drug Discovery With Quantum Algorithms - Benzinga
- 12 days ago - SciSparc Resolves to Launch Innovative Quantum Computing-Enabled 3D Protein Modeling Initiative to Revolutionize AI Drug Discovery - GlobeNewsWire
- 5 weeks ago - SciSparc: AutoMax's Shareholders Approve Merger with SciSparc - GlobeNewsWire
- 5 weeks ago - SciSparc Shareholders Approve Merger with a Leading Parallel Vehicle Importer in Israel - GlobeNewsWire
- 2 months ago - SciSparc-Clearmind Collaboration Leads to Publication of International Patent Application for Novel Combination Therapy Targeting Obesity and High Blood Sugar - GlobeNewsWire
- 2 months ago - SciSparc Announces Updates Regarding Proposed Merger; Form F-4 Registration Statement Has Been Declared Effective by SEC - GlobeNewsWire